(Q44402980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Long‐term follow‐up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease (English)

1 reference

DOI

https://api.crossref.org/works/10.1034/J.1399-0039.2003.00015.X

24 December 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1399-0039.2003.00015.X

24 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1399-0039.2003.00015.X

24 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1399-0039.2003.00015.X

24 December 2023

author name string

K. Yoshizawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

M. Ota

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

S. Saito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

A. Maruyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

T. Yamaura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

A. Rokuhara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

K. Orii

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

T. Ichijo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

A. Matsumoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

E. Tanaka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

K. Kiyosawa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694584

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694584

24 December 2023

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1399-0039.2003.00015.x

1 reference

DOI

https://api.crossref.org/works/10.1034/J.1399-0039.2003.00015.X

24 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

159-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

45-year follow-up of hepatitis C virus infection in healthy young adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Natural history of hepatitis C: its impact on clinical management

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Chronic viral hepatitis and the human genome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2003.00015.X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12694584%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference